v3.26.1
OTHER RECEIVABLES, PREPAYMENTS AND OTHER CURRENT ASSETS, PREPAYMENTS AND OTHER NON - CURRENT ASSETS
12 Months Ended
Dec. 31, 2025
OTHER RECEIVABLES, PREPAYMENTS AND OTHER CURRENT ASSETS, PREPAYMENTS AND OTHER NON - CURRENT ASSETS.  
OTHER RECEIVABLES, PREPAYMENTS AND OTHER CURRENT ASSETS, PREPAYMENTS AND OTHER NON - CURRENT ASSETS

6.OTHER RECEIVABLES, PREPAYMENTS AND OTHER CURRENT ASSETS, PREPAYMENTS AND OTHER NON - CURRENT ASSETS

Other receivables consist of the following:

As of December 31, 

  ​ ​ ​

2024

  ​ ​ ​

2025

Interest receivables

575

634

Other receivables

 

 

66

$

575

$

700

Prepayments and other current assets consist of the following:

As of December 31, 

  ​ ​ ​

2024

  ​ ​ ​

2025

Prepaid insurance premiums

$

414

$

641

Other prepayments for research and development expense (1)

916

486

Deductible value-added tax input

 

19

 

18

Other current assets

5

$

1,349

$

1,150

(1) Other prepayments for research and development expense represents payments made to third party contract research organizations (“CROs”) for pass-through expenses.

Prepayments and other non-current assets consist of the following:

  ​ ​ ​

As of December 31, 

  ​ ​ ​

2024

  ​ ​ ​

2025

Prepaid insurance premiums

 

$

27

  ​

$

172

Other prepayments for research and development expense (2)

 

 

3,933

  ​

 

4,897

 

$

3,960

  ​

$

5,069

(2) Other prepayments for research and development expense represents payments made to third party CROs to assist in the performance of clinical trial activities and the contract duration is expected to be 5 years.